21-Gene Recurrence Score and Adjuvant Chemotherapy Decision for Breast Cancer Patients with Positive Lymph Nodes

The 21-gene recurrence score (RS) assay is prognostic and predictive for hormone receptor (HR)+/HER2-/node- breast cancer (BC) patients. However, its clinical value in node + patients hasn’t been elucidated. HR+/HER2-/pN1 patients operated in Comprehensive Breast Health Center, Shanghai Ruijin Hospi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Yiwei, Wu, Jiayi, Huang, Ou, He, Jianrong, Zhu, Li, Chen, Weiguo, Li, Yafen, Chen, Xiaosong, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739381/
https://www.ncbi.nlm.nih.gov/pubmed/31511599
http://dx.doi.org/10.1038/s41598-019-49644-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739381/
https://www.ncbi.nlm.nih.gov/pubmed/31511599
http://dx.doi.org/10.1038/s41598-019-49644-6

Ejemplares similares